Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
25 hedge funds and large institutions have $487K invested in Monogram Orthopaedics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
39% more funds holding
Funds holding: 18 → 25 (+7)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.9% less ownership
Funds ownership: 1.35% → 0.45% (-0.9%)
53% less capital invested
Capital invested by funds: $1.03M → $487K (-$542K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$97.4K |
| 2 |
NHFG
New Harbor Financial Group
Worcester,
Massachusetts
|
+$88.5K |
| 3 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$32.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.6K |
| 5 |
Morgan Stanley
New York
|
+$4.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPAS
Focus Partners Advisor Solutions
Saint Louis,
Missouri
|
-$524K |
| 2 |
Millennium Management
New York
|
-$302K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$122K |
| 4 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
-$603 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$301 |
MGRM Hedge Fund Activity: Q4 2023 in Review
25 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q4 2023, worth a combined $487K — down 53% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MGRM positions and 1 closed out — a net gain of 7 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $97.4K. The largest seller was Focus Partners Advisor Solutions, exiting entirely with an estimated $524K sold.
- 25 institutional investors held Monogram Orthopaedics (MGRM) as of Q4 2023, up from 18 in Q3 2023.
- Funds reported $487K of Monogram Orthopaedics stock for Q4 2023, down 53% quarter-over-quarter.
- 8 funds opened new Monogram Orthopaedics positions in Q4 2023 and 1 closed out, a net change of +7 holders.
- The largest Monogram Orthopaedics buyer in Q4 2023 was Renaissance Technologies, an estimated $97.4K added.
- The largest Monogram Orthopaedics seller in Q4 2023 was Focus Partners Advisor Solutions, an estimated $524K sold.
Based on aggregated 13F filings for Q4 2023.